Journal of Medicinal Chemistry
Volume 41, Issue 27 (December 31, 1998)
Copyright © 1998
American Chemical Society
| PERSPECTIVE | |
5337-5352 | Leptin, a Pleiotropic Hormone: Physiology, Pharmacology, and Strategies for Discovery of Leptin Modulators
|
|
ARTICLES | |
5353-5361 | Novel Analogues of Arachidonylethanolamide (Anandamide): Affinities for the CB1 and CB2 Cannabinoid Receptors and Metabolic Stability
|
5362-5374 | Development of Dual-Acting Agents for Thromboxane Receptor Antagonism and Thromboxane Synthase Inhibition. 3. Synthesis and Biological Activities of Oxazolecarboxamide-Substituted  -Phenyl--(3-pyridyl)alkenoic Acid Derivatives and Related Compounds
|
5375-5381 | The 16,17-Double Bond Is Needed for Irreversible Inhibition of Human Cytochrome P45017 by Abiraterone (17-(3-Pyridyl)androsta-5,16-dien-3 -ol) and Related Steroidal Inhibitors
|
5382-5392 | Evaluation of Dynamic Polar Molecular Surface Area as Predictor of Drug Absorption: Comparison with Other Computational and Experimental Predictors
|
5393-5401 | New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, Endowed with Both Nitric Oxide-like and Calcium Channel Antagonist Vasodilator Activities
|
5402-5409 | 7-[3-(1-Piperidinyl)propoxy]chromenones as Potential Atypical Antipsychotics. 2. Pharmacological Profile of 7-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-piperidin-1-yl]propoxy]-3-(hydroxymethyl)chromen-4-one (Abaperidone, FI-8602)
|
5410-5419 | Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
|
5420-5428 | 4-(trans-4-Methylcyclohexyl)-4-Oxobutyric Acid (JTT-608). A New Class of Antidiabetic Agent
|
5429-5444 | Synthesis and Antitumor Evaluation of 2,5-Disubstituted- Indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-Aza-anthrapyrazoles)
|
5445-5456 | Structural and Functional Analyses of Benzamidine-Based Inhibitors in Complex with Trypsin: Implications for the Inhibition of Factor Xa, tPA, and Urokinase
|
5457-5465 | Structure-Activity Relationships for 1-Phenylbenzimidazoles as Selective ATP Site Inhibitors of the Platelet-Derived Growth Factor Receptor
|